Literature DB >> 28094969

Investigating Biogenetic Hypotheses of the Securinega Alkaloids: Enantioselective Total Syntheses of Secu'amamine E/ent-Virosine A and Bubbialine.

Robin Wehlauch1,2, Simone M Grendelmeier1, Hideki Miyatake-Ondozabal2, Alexander H Sandtorv2, Manuel Scherer1,2, Karl Gademann1.   

Abstract

The synthesis of the Securinega alkaloid secu'amamine E (ent-virosine A) has been accomplished for the first time in 12 steps and 8.5% overall yield. In addition, bubbialine has been prepared and characterized. These two alkaloids and bubbialidine, all featuring an azabicyclo[2.2.2]octane core, were rearranged to their azabicyclo[3.2.1]octane congeners, a framework found in many Securinega alkaloids. These experiments suggest that azabicyclo[2.2.2]octane derivatives could serve as intermediates in the biosynthesis of the rearranged azabicyclo[3.2.1]octane products.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28094969     DOI: 10.1021/acs.orglett.6b03716

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  Synthesis and Evaluation of Marine Natural Product-Inspired Meroterpenoids with Selective Activity toward Dormant Mycobacterium tuberculosis.

Authors:  Anshupriya Si; Alexander D Landgraf; Sandra Geden; Steven J Sucheck; Kyle H Rohde
Journal:  ACS Omega       Date:  2022-06-27

2.  Enantiocontrolled Preparation of ϒ-Substituted Cyclohexenones: Synthesis and Kinase Activity Assays of Cyclopropyl-Fused Cyclohexane Nucleosides.

Authors:  Sergio Jurado; Beatriz Domínguez-Pérez; Ona Illa; Jan Balzarini; Félix Busqué; Ramon Alibés
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

3.  Collective total synthesis of C4-oxygenated securinine-type alkaloids via stereocontrolled diversifications on the piperidine core.

Authors:  Sangbin Park; Gyumin Kang; Chansu Kim; Dongwook Kim; Sunkyu Han
Journal:  Nat Commun       Date:  2022-09-02       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.